InvestorsHub Logo
Followers 0
Posts 642
Boards Moderated 0
Alias Born 07/13/2017

Re: None

Friday, 02/16/2018 11:19:07 AM

Friday, February 16, 2018 11:19:07 AM

Post# of 3176
The cardiopass was ahead of its time, those rights have to be worth something. They had a sheath over the chronoflex graft and seeded patient cells in the graft to form a pulsating fully synthetic heart bypass graft. Some patients lived for several years with graft with no complications,then the just dropped it. Advansource still owns rights to cardiopass and its recearch
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NORD News